229 related articles for article (PubMed ID: 30531139)
41. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
42. [Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].
Sumi C; Toki Y; Funayama T; Saito T; Hatayama M; Yamamoto M; Shindo M; Yuzawa S; Tanino M; Okumura T
Rinsho Ketsueki; 2023; 64(4):265-270. PubMed ID: 37121770
[TBL] [Abstract][Full Text] [Related]
43. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
Akagi Y; Kato T; Yamashita Y; Hosoi H; Murata S; Yamamoto S; Warigaya K; Nakao T; Murata S; Sonoki T; Tamura S
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577894
[TBL] [Abstract][Full Text] [Related]
44. A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction.
Kanda M; Kitamura K; Saito A; Hayashi K; Suzuki T
Cureus; 2024 Apr; 16(4):e58772. PubMed ID: 38779246
[TBL] [Abstract][Full Text] [Related]
45. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
[TBL] [Abstract][Full Text] [Related]
46. [TAFRO syndrome and cutaneous necrotizing vasculitis].
Maquet J; Bories E; Nogier MB; Beck C; Aizel G; Toledano A; Faguer S; Paricaud K; Pugnet G; Moulis G; Astudillo L; Sailler L
Rev Med Interne; 2021 Feb; 42(2):134-139. PubMed ID: 33218790
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237
[TBL] [Abstract][Full Text] [Related]
48. Thrombocytopenia, Anasarca, Myelofibrosis, Renal dysfunction, and Organomegaly (TAFRO) Syndrome Initially Diagnosed as Fibromyalgia: A Case Report.
Ohta R; Sano C
Cureus; 2023 Jul; 15(7):e42514. PubMed ID: 37637539
[TBL] [Abstract][Full Text] [Related]
49. Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.
Ohya E; Mizutani M; Sakaguchi H; Sekine T
Intern Med; 2016; 55(19):2861-2867. PubMed ID: 27725549
[TBL] [Abstract][Full Text] [Related]
50. Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease.
Tosaki T; Okabe M; Suzuki T; Shimizu A; Koike K; Tsuboi N; Kawamura T; Ohashi R; Yano S; Yokoo T
CEN Case Rep; 2021 May; 10(2):265-272. PubMed ID: 33389670
[TBL] [Abstract][Full Text] [Related]
51. A rare case of renal thrombotic microangiopathy associated with Castleman's disease.
Mutneja A; Cossey LN; Liapis H; Chen YM
BMC Nephrol; 2017 Feb; 18(1):57. PubMed ID: 28183278
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab.
Suzuki K; Matsumoto T; Iwashita Y; Ishikura K; Fujioka M; Wada H; Katayama N; Imai H
Int J Hematol; 2019 Jun; 109(6):737-743. PubMed ID: 30680669
[TBL] [Abstract][Full Text] [Related]
53. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
Wakiya R; Kameda T; Takeuchi Y; Ozaki H; Nakashima S; Shimada H; Kadowaki N; Dobashi H
Mod Rheumatol Case Rep; 2021 Jan; 5(1):145-151. PubMed ID: 33269653
[TBL] [Abstract][Full Text] [Related]
54. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.
Noda-Narita S; Sumida K; Sekine A; Hoshino J; Mise K; Suwabe T; Hayami N; Yamanouchi M; Ueno T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
CEN Case Rep; 2018 May; 7(1):162-168. PubMed ID: 29468524
[TBL] [Abstract][Full Text] [Related]
55. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
[TBL] [Abstract][Full Text] [Related]
56. [TAFRO syndrome, variant of Castleman's disease: case report].
Sánchez-Pardo S; Rojas-Holguín DF; Choi-Park I; Osorio-Ramírez JA; Bolívar-Mejía A
Rev Med Inst Mex Seguro Soc; 2020 Nov; 58(6):734-739. PubMed ID: 34705406
[TBL] [Abstract][Full Text] [Related]
57. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.
Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N
CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358
[TBL] [Abstract][Full Text] [Related]
58. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.
Iwasaki T; Mizusaki K; Masumoto M; Minagawa Y; Azuma K; Furukawa T; Yoshida M; Kuragano T
BMC Nephrol; 2022 Jul; 23(1):262. PubMed ID: 35870879
[TBL] [Abstract][Full Text] [Related]
59. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities.
Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O
Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781
[TBL] [Abstract][Full Text] [Related]
60. Liver cirrhosis in a child associated with Castleman's disease: A case report.
Kobayashi S; Inui A; Tsunoda T; Umetsu S; Sogo T; Mori M; Shinkai M; Fujisawa T
World J Clin Cases; 2020 May; 8(9):1656-1665. PubMed ID: 32432144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
